First Published on July 15th, 2022 by Bob Ciura for SureDividend
DRIP stands for Dividend Reinvestment Plan. When an investor is enrolled in DRIP stocks, it means that incoming dividend payments are used to purchase more shares of the issuing company – automatically.
Many businesses offer DRIPs that require the investors to pay fees. Obviously, paying fees is a negative for investors. As a general rule, investors are better off avoiding DRIP stocks that charge fees.
Fortunately, many companies offer no-fee DRIP stocks. These allow investors to use their hard-earned dividends to build even larger positions in their favorite high-quality, dividend-paying companies – for free.
Dividend Aristocrats are the perfect form of DRIP stocks. Dividend Aristocrats are elite companies that satisfy the following:
- Are in the S&P 500 Index
- Have 25+ consecutive years of dividend increases
- Meet certain minimum size & liquidity requirements
You can download an Excel spreadsheet with the full list of all 66 Dividend Aristocrats (with additional financial metrics such as price-to-earnings ratios and dividend yields) by clicking the link below:
Click here to download your Dividend Aristocrats Excel Spreadsheet List now.
Think about the powerful combination of DRIPs and Dividend Aristocrats…
You are reinvesting dividends into a company that pays higher dividends every year. This means that every year you get more shares – and each share is paying you more dividend income than the previous year.
This makes a powerful (and cost-effective) compounding machine.
This article takes a look at the top 15 Dividend Aristocrats that are no-fee DRIP stocks, ranked in order of expected total returns from lowest to highest.
The updated list for 2022 includes our top 15 Dividend Aristocrats, ranked by expected returns according to the Sure Analysis Research Database, that offer no-fee DRIPs to shareholders.
You can skip to analysis of any individual Dividend Aristocrat below:
- #15: Chubb Limited (CB)
- #14: Abbott Laboratories (ABT)
- #13: Hormel Foods (HRL)
- #12: AbbVie Inc. (ABBV)
- #11: Sherwin-Williams (SHW)
- #10: Aflac Incorporated (AFL)
- #9: Federal Realty Investment Trust (FRT)
- #8: Johnson & Johnson (JNJ)
- #7: Realty Income (O)
- #6: S&P Global Inc. (SPGI)
- #5: Illinois Tool Works (ITW)
- #4: Albemarle Corporation (ALB)
- #3: Emerson Electric (EMR)
- #2: A.O. Smith (AOS)
- #1: 3M Company (MMM)
Additionally, please see the video below for more coverage.https://www.youtube.com/embed/VwKe03oYrHI
In this article
No-Fee DRIP Dividend Aristocrat #15: Chubb Limited (CB)
- 5-year expected annual returns: 4.3%
Chubb Ltd is a global provider of insurance and reinsurance services headquartered in Zurich, Switzerland. The company provides insurance services including property & casualty insurance, accident & health insurance, life insurance, and reinsurance.
The current version of Chubb was created in 2016, when Ace Limited acquired the ‘old’ Chubb and adopted its name. Chubb has a large and diversified product portfolio.
Source: Investor Presentation
Chubb reported its first quarter earnings results on April 26. The company reported that its revenues totaled $8.8 billion during the quarter, which was 6% more than the revenues that Chubb generated during the previous year’s quarter.
Net written premiums were up 8% year-over-year in Chubb’s P&C segment at constant currency rates, which was slightly weaker than the growth recorded in the previous quarter. Chubb was able to generate net investment income of $900million during the quarter, which was flat on a sequential basis.
Chubb generated earnings-per-share of $3.82 during the first quarter, which was easily ahead of what the analyst community had forecasted. Chubb’s solid profitability during the quarter can be explained by a very healthy combined ratio, despite some natural disasters that impacted Chubb’s catastrophe losses.
Thanks to written premium growth and tailwinds from share repurchases, Chubb’s profits could be strong in the coming quarters as well, unless the company feels an impact from above-average catastrophe losses, which generally aren’t predicable. Chubb’s book value was down during the period, mainly due to mark-to-market losses, ending the quarter at $133.80.
Click here to download our most recent Sure Analysis report on Chubb (preview of page 1 of 3 shown below):
No-Fee DRIP Dividend Aristocrat #14: Abbott Laboratories (ABT)
- 5-year expected annual returns: 4.5%
Abbott Laboratories is one of the largest medical appliances & equipment manufacturers in the world, comprised of four segments: Nutrition, Diagnostics, Established Pharmaceuticals and Medical Devices.
Abbott has increased its dividend for 50 years. Abbott has a large and diversified product portfolio, with leadership across multiple categories.
On April 20th, 2022, Abbott Laboratories reported first quarter results for the period ending March 31st, 2022. For the quarter the company generated $11.9 billion in sales (58% outside of the U.S.) representing a 13.3% increase compared to the first quarter of 2021. Adjusted earnings-per-share of $1.73 compared very favorably to $1.32 in the prior year.
Company-wide organic sales growth was 17.5%. Results were up almost across the board with Diagnostics, Established Pharmaceuticals, and Medical Devices organic sales increasing 35.1%%, 13.4%, and 11.5% respectively. Nutrition declined 4.4% due to a voluntary recall of certain powder formulas in the U.S.
Abbott Laboratories reaffirmed 2022 guidance, anticipating at least $4.70 in adjusted earnings-per-share for the year.
With a P/E near 25, Abbott appears overvalued. Our fair value estimate is a P/E of 20. Overvaluation could significantly weigh on shareholder returns going forward.
Expected EPS growth of 5% per year plus the 1.6% dividend yield will offset the impact of a declining P/E multiple, but total returns are expected at just 2.1% per year over the next five years.
Click here to download our most recent Sure Analysis report on Abbott Laboratories (preview of page 1 of 3 shown below):
No-Fee DRIP Dividend Aristocrat #13: Hormel Foods (HRL)
- 5-year expected annual returns: 4.8%
Hormel Foods was founded back in 1891 in Minnesota. Since that time, the company has grown into a juggernaut in the food products industry with nearly $10 billion in annual revenue.
Hormel has kept with its core competency as a processor of meat products for well over a hundred years, but has also grown into other business lines through acquisitions.
Hormel has a large portfolio of category-leading brands. Just a few of its top brands include include Skippy, SPAM, Applegate, Justin’s, and more than 30 others.
Hormel reported second quarter earnings on June 2nd, 2022, and results were better than expected on both the top and bottom lines. Earnings-per-share came to 48 cents, which was a penny ahead of estimates. Revenue was up 19% from last year’s Q2, hitting $3.1 billion, and $30 million better than estimates.
Source: Investor Presentation
Volume was 1.2 billion pounds, down 2% on a headline basis. Organic volume was down 8%, which excludes acquisitions and divestitures. However, strong pricing helped organic sales rise 10% despite the decline in volumes, and Q2 revenue was a record for Hormel.
Refrigerated foods saw volume decline 13%, as organic volume fell 14%. Net sales were up 13%, led by organic sales of +11% on strong pricing. Segment profit was up just 3% as rising revenue was largely offset by higher costs. Grocery products saw volume rise 19% as organic volume was up 2%. Net sales rose 39% as organic sales were up 7%. The difference was the Planters acquisition. Segment profit declined 9%.
Click here to download our most recent Sure Analysis report on Hormel (preview of page 1 of 3 shown below):
No-Fee DRIP Dividend Aristocrat #12: AbbVie Inc. (ABBV)
- 5-year expected annual returns: 4.9%
AbbVie Inc. is a pharmaceutical company spun off by Abbott Laboratories (ABT) in 2013. Its most important product is Humira, which is now facing biosimilar competition in Europe, which has had a noticeable impact on the company. Humira will lose patent protection in the U.S. in 2023.
Even so, AbbVie remains a giant in the healthcare sector, with a large and diversified product portfolio.
AbbVie reported its first quarter earnings results on April 29. The company was able to generate revenues of $13.5 billion during the quarter, which was 4% more than AbbVie’s revenues during the previous year’s quarter. Revenues were positively impacted by healthy growth from some of its drugs, including Skyrizi and Rinvoq.
AbbVie earned $3.16 per share during the first quarter, which was 9% more than the company’s earnings-per-share during the previous year’s quarter. AbbVie’s earnings-per-share beat the consensus analyst estimate by $0.02. AbbVie’s guidance for 2022’s adjusted earnings-per-share was lowered slightly during the earnings call, the company now expects to earn $13.92 – $14.12 on a per-share basis this year.
Click here to download our most recent Sure Analysis report on AbbVie (preview of page 1 of 3 shown below):
No-Fee DRIP Dividend Aristocrat #11: Sherwin-Williams (SHW)
- 5-year expected annual returns: 5.6%
Sherwin-Williams, founded in 1866 and headquartered in Cleveland, OH, is North America’s largest manufacturer of paints and coatings.
The company distributes its products through wholesalers as well as retail stores (including a chain of more than 4,900 company-operated stores and facilities) to 120 countries under the Sherwin-Williams name.
The company also manufactures Dutch Boy, Pratt & Lambert, Minwax, Thompson’s Waterseal, Krylon, Valspar (acquired in 2017), and other brands.
Source: Investor Presentation
On April 26th, 2022, Sherwin-Williams released Q1 2022 results for the period ending March 31st, 2022. For the quarter Sherwin-Williams generated revenue of $4.999 billion, a 7.4% increase compared to Q1 2021. A 5.6% increase in the Americas Group and a 20.4% increase in the Performance Coatings Group were partially offset by a 10.1% decline in the Consumer Brands Group. Adjusted earnings-per-share equaled $1.61 versus $2.06 in Q1 2021.
Sherwin-Williams also reiterated its 2022 guidance, anticipating high-single digit to low-double digit sales growth and $9.25 to $9.65 in adjusted earnings-per-share.
The stock trades for more than 25 times earnings. We believe shares are significantly overvalued today. The combination of valuation changes, 7% annual EPS growth, and the 0.9% dividend yield result in expected annual returns of 4.4% per year.
Click here to download our most recent Sure Analysis report on Sherwin-Williams (preview of page 1 of 3 shown below):
No-Fee DRIP Dividend Aristocrat #10: Aflac Inc. (AFL)
- 5-year expected annual returns: 6.2%
Aflac was formed in 1955, when three brothers — John, Paul, and Bill Amos — came up with the idea to sell insurance products that paid cash if a policyholder got sick or injured. In the mid-20th century, workplace injuries were common, with no insurance product at the time to cover this risk.
Related: Detailed analysis on the best insurance stocks.
Today, Aflac has a wide range of product offerings, some of which include accident, short-term disability, critical illness, hospital indemnity, dental, vision, and life insurance.
The company specializes in supplemental insurance, which pays out to policy holders if they are sick or injured, and cannot work. Aflac operates in the U.S. and Japan, with Japan accounting for approximately 70% of the company’s revenue. Because of this, investors are exposed to currency risk.
In general terms, Aflac has two sources of income: income from premiums and income from investments. Taking the items collectively, in addition to an active share repurchase program, reasonable expectations would be for 4% annual earnings-per-share growth over the next five years.
Shares appear slightly over-valued right now. The current dividend yield of 2.7%, plus 4% expected EPS growth, leads to total expected returns of 6.2% per year.
Click here to download our most recent Sure Analysis report on Aflac (preview of page 1 of 3 shown below):
No-Fee DRIP Dividend Aristocrat #9: Federal Realty Investment Trust (FRT)
- 5-year expected annual returns: 7.6%
Federal Realty was founded in 1962. As a Real Estate Investment Trust, Federal Realty’s business model is to own and rent out real estate properties. It uses a significant portion of its rental income, as well as external financing, to acquire new properties. This helps create a “snow-ball” effect of rising income over time.
Federal Realty primarily owns shopping centers. However, it also operates in redevelopment of multi-purpose properties including retail, apartments, and condominiums. The portfolio is highly diversified in terms of tenant base.
Source: Investor Presentation
Federal Realty reported Q1 earnings on 05/05/22. FFO per share came in at $1.50, up from $1.17 in the year-ago quarter. Total revenue increased 17.7% to $256.77M year-over-year. Net income available for common shareholders stood at $0.63, up from $0.60 in the year-ago period. During the quarter, Federal Realty continued record levels of leasing with 119 signed leases for 444,398 square feet of comparable space.
The trust’s portfolio, during the quarter, was 91.2% occupied and 93.7% leased, up by 170 basis points and 190 basis points, respectively, year-over-year. That said, the trust maintained a 250 basis points spread between occupied and leased. Moreover, small shop leased rate was 88.7%, up by 130 basis points quarter-over-quarter. Federal Realty also reported Q1 comparable property operating income growth of 14.5%.
Meanwhile, the company raised its 2022 earnings per share guidance to $2.36-$2.56 from $2.30-$2.50 and FFO per diluted share guidance to $5.85-$6.05 from $5.75-$5.95.
Click here to download our most recent Sure Analysis report on Federal Realty (preview of page 1 of 3 shown below):
No-Fee DRIP Dividend Aristocrat #8: Johnson & Johnson (JNJ)
- 5-year expected annual returns: 8.1%
Johnson & Johnson is a diversified health care company and a leader in the area of pharmaceuticals (~49% of sales), medical devices (~34% of sales) and consumer products (~17% of sales). The company has annual sales in excess of $93 billion.
Source: Investor Presentation
On April 19th, 2022, Johnson & Johnson released first quarter earnings results for the period ending March 31st, 2022. Revenue increased 5% to $23.4 billion, but missed estimates by $210 million. Adjusted earnings-per-share of $2.67 compared to $2.59 in the prior year and was $0.10 better than expected.
Pharmaceutical revenues were up 6.3%, with Oncology leading the way with another quarter of 10%+ growth. Consumer revenue fell 1.5% as strength in Over-the-Counter and Women’s Health was more than offset by weaker results in the remaining businesses. MedTech again showed that the recovery from the Covid-19 pandemic continues as sales were higher by 5.9%, a sequential acceleration.
Johnson & Johnson offered revised guidance for the year. The company now expects adjusted earnings-per-share of $10.15 to $10.30 for 2022, down from $10.40 to $10.60 previously, and revenue of $97.3 billion to $98.3 billion, down from $98.9 billion and $100.4 billion.
Click here to download our most recent Sure Analysis report on J&J (preview of page 1 of 3 shown below):
No-Fee DRIP Dividend Aristocrat #7: Realty Income (O)
- 5-year expected annual returns: 8.5%
Realty Income is a retail-focused REIT that owns more than 6,500 properties. It owns retail properties that are not part of a wider retail development (such as a mall), but instead are standalone properties.
This means that the properties are viable for many different tenants, including government services, healthcare services, and entertainment.
Source: Investor Presentation
The company’s long history of dividend payments and increases is due to its high-quality business model and diversified property portfolio.
Realty Income announced its first quarter earnings results on May 4. The trust reported that it generated revenues of $810 million during the quarter, which was 82% more than the revenues that Realty Income generated during the previous year’s quarter. Realty investments into new properties and its acquisition of VEREIT that closed in late 2021 impacted the year-over-year comparison to a large degree.
Realty Income’s funds-from-operations rose substantially versus the prior year’s quarter, although AFFO-per-share growth was lower, due to share issuance. Realty Income nevertheless managed to generate funds-from-operations-per share of $0.98 during the quarter. Realty Income expects that its results during 2022 will represent a new record, as funds from operations are forecasted to come in at ~$3.97 on a per-share basis during fiscal 2022.
Realty Income’s acquisition of VEREIT, which closed last November, is responsible for the majority of the forecasted growth in this year’s results, despite the dilution that was caused by the shares that were issued for the takeover.
Click here to download our most recent Sure Analysis report on Realty Income (preview of page 1 of 3 shown below):
No-Fee DRIP Dividend Aristocrat #6: S&P Global Inc. (SPGI)
- 5-year expected annual returns: 9.2%
S&P Global is a worldwide provider of financial services and business information. The company has generated strong growth over the past several years.
S&P reported first quarter earnings on May 3rd, 2022, and results were weaker than expected on both the top and bottom lines. The company posted $2.89 in earnings-per-share, which missed estimates by eight cents.
In addition, while revenue was up 18% year-over-year to $2.39 billion, it missed estimates by $650 million. Revenue growth was driven by improvements in five of the company’s six divisions, which was partially offset by a sharp decline in revenue related to debt issuances. As prevailing interest rates rise, this is likely to continue to be a headwind for S&P.
Following the consummation of the IHS Markit acquisition, management now expects revenue to rise at least 40% this year. Earnings-per-share on an adjusted basis is now expected in the range of $13.40 to $13.60.
Click here to download our most recent Sure Analysis report on S&P Global (preview of page 1 of 3 shown below):
No-Fee DRIP Dividend Aristocrat #5: Illinois Tool Works (ITW)
- 5-year expected annual returns: 9.2%
Illinois Tool Works is a diversified multi-industrial manufacturer with seven unique operating segments: Automotive, Food Equipment, Test & Measurement, Welding, Polymers & Fluids, Construction Products and Specialty Products.
On May 3rd, 2022, Illinois Tool Works reported first quarter 2022 results for the period ending March 31st, 2022. For the quarter, revenue came in at $3.9 billion, up 11.2% compared to Q1 2021.
Source: Investor Presentation
Sales were down -1% in the Automotive segment due to supply shortages but were up 0.6% to 28.2% in the other six segments. Net income equaled $662 million or $2.11 per share compared to $671 million or $2.11 per share in Q1 2021. The increase in net income per share is a result of a lower year-over-year share count.
Illinois Tool Works also increased its 2022 guidance. For this year, the company anticipates 8.5% to 11.5% (up from 7.5% to 10.5%) revenue growth and $9.00 to $9.40 (up from $8.90 to $9.30) in earnings-per-share.
Illinois Tool Works has an excellent dividend growth history. Its payout ratio was relatively high during the last financial crisis, but the company was not forced to cut the payout. Today the dividend payout ratio sits at 53% of expected earnings, above the company’s long-term target, meaning that future dividend growth may trail earnings growth.
Click here to download our most recent Sure Analysis report on ITW (preview of page 1 of 3 shown below):
No-Fee DRIP Dividend Aristocrat #4: Albemarle Corporation (ALB)
- 5-year expected annual returns: 10.4%
Albemarle is the largest producer of lithium and second largest producer of bromine in the world. The two products
account for nearly two-thirds of annual sales. Albemarle produces lithium from its salt brine deposits in the U.S. and
Chile. The company has two joint ventures in Australia that also produce lithium. Albemarle’s Chile assets offer a very low-cost source of lithium.
The company operates in nearly 100 countries and is composed of four segments. Albemarle produces annual sales of more than $5 billion.
Source: Investor Presentation
On May 4th, 2022, Albemarle released first quarter results for the period ending March 31st, 2022. Revenue grew 36.3% to $1.13 billion, $100 million better than expected. Adjusted earnings-per-share of $2.38 compared very favorably to $1.10 in the prior year and was $0.75 above estimates.
Revenue for Lithium surged 97% to $550.3 million, due to a 66% improvement in pricing and a 31% increase in volume due to higher customer demand. The company expects volume growth to be 20% to 30% for the year. Revenues for Bromine Specialties grew 28.2% to $359.6 million as pricing added 25% and volume improved 3%. Catalysts fell by 1.1% to $217.9 million.
Albemarle provided an outlook for 2022 as well, with the company expecting revenue of $5.2 billion to $5.6 billion, up from $4.2 billion to $4.5 billion previously. Adjusted earnings-per-share are now projected to be in a range of $9.25 to $12.25, up significantly from $5.65 to $6.65 previously.
Click here to download our most recent Sure Analysis report on Albemarle (preview of page 1 of 3 shown below):
No-Fee DRIP Dividend Aristocrat #3: Emerson Electric (EMR)
- 5-year expected annual returns: 11.5%
Emerson Electric is an ideal candidate for a no-fee DRIP program, as the company has increased its dividend for over 60 years in a row.
Emerson Electric was founded in Missouri in 1890 and since that time, it has evolved through organic growth, as well as strategic acquisitions and divestitures, from a regional manufacturer of electric motors and fans into a $49 billion diversified global leader in technology and engineering. Its global customer base and diverse product and service offerings afford it about $20 billion in annual revenue. The company has increased its dividend for 65 years in a row.
Emerson reported second quarter earnings on May 4th, 2022, and results were better than expected on both the top and bottom lines. Adjusted earnings-per-share came to $1.29, beating expectations by 11 cents. Revenue was $4.8 billion, up 8% year-over-year and $80 million better than estimates.
Sales in Automation Solutions rose 5% to $2.93 billion, while Commercial and Residential Solutions saw sales rise 13% to $1.85 billion. Net profit was $674 million, up from $561 million year-over-year. Adjusted EBITA margin was up 20 basis points to 20.2% of revenue.
Free cash flow for Q2 fell by half year-over-year to $333 million, which was attributable to higher inventory resulting from supply chain constraints. The company raised guidance for this year to adjusted earnings-per-share of $4.95 to $5.10, up about 25 cents from prior guidance.
Expected returns could reach 11.5%, driven by 5% EPS growth, the 2.6% dividend yield, and a ~3.9% return from an expanding P/E multiple.
Click here to download our most recent Sure Analysis report on EMR (preview of page 1 of 3 shown below):
No-Fee DRIP Dividend Aristocrat #2: A.O. Smith (AOS)
- 5-year expected annual returns: 12.0%
A.O. Smith is a leading manufacturer of residential and commercial water heaters, boilers and water treatment products. A.O. Smith generates the majority of its sales in North America, with the remainder from the rest of the world. It has category-leading brands across its various geographic markets.
A.O. Smith reported its first quarter earnings results on April 28. The company generated revenues of $980 million during the quarter, which represents an increase of 27% compared to the prior year’s quarter. A.O. Smith’s revenues were up 32% in North America, while revenue growth was lower in the rest of the world, where sales during the quarter were up 15% year over year, with the lower growth rate being explained by factors such as COVID measures in China.
A.O. Smith generated earnings-per-share of $0.77 during the first quarter, which was up by 31% on a year over year basis. This can mostly be explained by the solid revenue performance, which lifted the company’s profits at a comparable level, despite commodity price headwinds.
A.O. Smith has also reaffirmed its guidance for 2022. The company is forecasting earnings-per-share in a range of $3.35 and $3.55, which reflects that management expects earnings-per-share to meaningfully grow this year, on top of the strong growth in 2021. At the midpoint of the guidance range, A.O. Smith’s earnings-per-share would rise by an attractive 14% compared to 2021.
Click here to download our most recent Sure Analysis report on A.O. Smith (preview of page 1 of 3 shown below):
No-Fee DRIP Dividend Aristocrat #1: 3M Company (MMM)
- 5-year expected annual returns: 18.4%
3M sells more than 60,000 products that are used every day in homes, hospitals, office buildings and schools around the world. It has about 95,000employees and serves customers in more than 200 countries.
Source: Investor Presentation
3M is now composed of four separate divisions. The Safety & Industrial division produces tapes, abrasives, adhesives and supply chain management software as well as manufactures personal protective gear and security products.
The Healthcare segment supplies medical and surgical products as well as drug delivery systems. Transportation & Electronics division produces fibers and circuits with a goal of using renewable energy sources while reducing costs. The Consumer division sells office supplies, home improvement products, protective materials and stationary supplies.
On April 26th, 2022, 3M reported first quarter earnings results for the period ending March 31st, 2022. Revenue fell 0.3% to $8.8 billion, but was $50 million better than expected. Adjusted earnings-per-share of $2.65 compared to $2.77 in the prior year, but was $0.34 above estimates. Organic growth for the quarter was 2%.
3M provided an updated outlook for 2022, with the company now expecting adjusted earnings-per-share of $10.75 to $11.25.
Click here to download our most recent Sure Analysis report on 3M (preview of page 1 of 3 shown below):
Final Thoughts and Additional Resources
Enrolling in DRIP stocks can be a great way to compound your portfolio income over time.
Additional resources are listed below for investors interested in further research for DRIP stocks.
For dividend growth investors interested in DRIP stocks, the 15 companies mentioned in this article are a great place to start. Each business is very shareholder friendly, as evidenced by their long dividend histories and their willingness to offer investors no-fee DRIP stocks.
At Sure Dividend, we often advocate for investing in companies with a high probability of increasing their dividends each and every year.
If that strategy appeals to you, it may be useful to browse through the following databases of dividend growth stocks:
- The High Yield Dividend Aristocrats List is comprised of the 20 Dividend Aristocrats with the highest current yields.
- The Dividend Achievers List is comprised of ~350 stocks with 10+ years of consecutive dividend increases.
- The Dividend Kings List is even more exclusive than the Dividend Aristocrats. It is comprised of 38 stocks with 50+ years of consecutive dividend increases.
- The High Yield Dividend Kings List is comprised of the 20 Dividend Kings with the highest current yields.
- The Blue Chip Stocks List: stocks that qualify as Dividend Achievers, Dividend Aristocrats, and/or Dividend Kings
- The High Dividend Stocks List: stocks that appeal to investors interested in the highest yields of 5% or more.
- The Monthly Dividend Stocks List: stocks that pay dividends every month, for 12 dividend payments per year.
- The Dividend Champions List: stocks that have increased their dividends for 25+ consecutive years.
Note: Not all Dividend Champions are Dividend Aristocrats because Dividend Aristocrats have additional requirements like being in The S&P 500. - The Dividend Contenders List: 10-24 consecutive years of dividend increases.
- The Dividend Challengers List: 5-9 consecutive years of dividend increases.
This article was first published by Bob Ciura for Sure Dividend
Sure dividend helps individual investors build high-quality dividend growth portfolios for the long run. The goal is financial freedom through an investment portfolio that pays rising dividend income over time. To this end, Sure Dividend provides a great deal of free information.
Related:
2022 REITs List | See All 208 Now | Yields Up To 19.2%
2022 Blue-Chip Dividend Stocks | See All 357 | Yields Up To 8.3%
Investing Globally; 5 Reasons on Why It’s Important
Warren Buffett Stocks: The Coca-Cola Company
